ES2079464T3 - Derivados dipeptidicos de muramilo. - Google Patents

Derivados dipeptidicos de muramilo.

Info

Publication number
ES2079464T3
ES2079464T3 ES90810480T ES90810480T ES2079464T3 ES 2079464 T3 ES2079464 T3 ES 2079464T3 ES 90810480 T ES90810480 T ES 90810480T ES 90810480 T ES90810480 T ES 90810480T ES 2079464 T3 ES2079464 T3 ES 2079464T3
Authority
ES
Spain
Prior art keywords
muramilo
dipeptidic
derivatives
compound
isoglutaminil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90810480T
Other languages
English (en)
Inventor
Peter Dukor
Pierre Lefrancier
Peter Stutz
Louis Chedid
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Application granted granted Critical
Publication of ES2079464T3 publication Critical patent/ES2079464T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

SE PRESENTA UN DERIVADO DEL 3-O-[N-ACETILMURAMIL-D-ISOGLUTAMINIL] - 1,2 DI - O- PALMITOIL-SN-GLICEROL DE LA FORMULA (I) EN DONDE EL ATOMO DE CARBONO MARCADO CON UN ASTERISCO TIENE LA CONFIGURACION R O S RESPECTIVAMENTE. ESTOS COMPUESTOS POSEEN INTERES FARMACOLOGICO, EN PARTICULAR PROPIEDADES INMUNOMODULANTES. SON INDICADOS PARTICULARMENTE PARA SU USO COMO INMUNOMODULANTES, COMO COADYUGANTES EN VACUNAS Y COMO AGENTES SUPRESORES PARA LA FORMACION DE IGE EN POR EJ. LAS ALERGIAS DE TIPO I Y LAS DERMATOSIS ATOPICAS. EL COMPUESTO SE OBTIENE MEDIANTE LA DESPROTECCION DE UN COMPUESTO CORRESPONDIENTE QUE TENGA UNO O MAS GRUPOS DE HIDROXIDO DE FORMA PROTEGIDA.
ES90810480T 1989-06-29 1990-06-26 Derivados dipeptidicos de muramilo. Expired - Lifetime ES2079464T3 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3921248 1989-06-29
DE3921246 1989-06-29
DE3924874 1989-07-27
DE3924875 1989-07-27

Publications (1)

Publication Number Publication Date
ES2079464T3 true ES2079464T3 (es) 1996-01-16

Family

ID=27434666

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90810480T Expired - Lifetime ES2079464T3 (es) 1989-06-29 1990-06-26 Derivados dipeptidicos de muramilo.

Country Status (17)

Country Link
US (1) US5210072A (es)
EP (1) EP0406175B1 (es)
JP (1) JPH0737479B2 (es)
KR (1) KR910000775A (es)
AT (1) ATE130313T1 (es)
AU (1) AU636150B2 (es)
CA (1) CA2019922A1 (es)
DE (1) DE69023559T2 (es)
ES (1) ES2079464T3 (es)
FI (1) FI903232A7 (es)
HU (1) HU205147B (es)
IE (1) IE902345A1 (es)
IL (1) IL94885A (es)
MY (1) MY105727A (es)
NZ (1) NZ234270A (es)
PL (1) PL163888B1 (es)
PT (1) PT94517A (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2054228A1 (en) * 1990-10-30 1992-05-01 Masaharu Oki Muramyldipeptide derivatives and influenza vaccine comprising the derivatives
US5919466A (en) * 1993-10-01 1999-07-06 Gerbu Biotechnik Gmbh Method for improving the yield of immunoantibodies in the vaccination of animals and humans
GB9320820D0 (en) * 1993-10-08 1993-12-01 Biokine Tech Ltd Compounds for medicinal use
GB9326518D0 (en) * 1993-12-29 1994-03-02 Sandoz Ltd Organic compounds
GB9413935D0 (en) * 1994-07-11 1994-08-31 Peptech Uk Ltd Use of maramyl peptide compounds
US6270758B1 (en) 1998-10-08 2001-08-07 Duke University Substantially non-toxic biologically active mucosal adjuvants in vertebrate subjects
US12134664B2 (en) 2015-12-10 2024-11-05 Bharat Biotech International Ltd. Muramyl peptide derivatives
EP3387005B1 (en) 2015-12-10 2022-08-24 Bharat Biotech International Limited Novel muramyl peptide derivative compound, synthesis and uses thereof
US10576147B2 (en) 2015-12-15 2020-03-03 Bharat Biotech International Limited Muramyl peptide derivative compound, synthesis and uses thereof
MX2020002010A (es) 2017-08-21 2020-07-13 Celgene Corp Procesos para la preparacion de 4,5-diamino-5-oxopentanoato de (s)-terc-butilo.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4897308A (en) * 1975-06-30 1990-01-30 L'oreal Compositions comprising aqueous dispersions of lipid spheres
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
FR2442241A2 (fr) * 1978-03-20 1980-06-20 Anvar Nouveaux composes esters de muramyl-peptide, leur preparation et les compositions pharmaceutiques les contenant, notamment sous forme de liposomes
US4315913A (en) * 1980-06-09 1982-02-16 Merck & Co. Inc. Immunologically active dipeptidyl 2-amino-1,2-dideoxy-D-glucose derivatives and methods of preparation
IL64397A0 (en) * 1981-01-07 1982-02-28 Weder Hans G Process for the preparation of liposomal medicaments
JPS58172399A (ja) * 1982-04-05 1983-10-11 Dai Ichi Seiyaku Co Ltd ムラミルトリペプチド誘導体
JPS6078997A (ja) * 1983-10-07 1985-05-04 Dai Ichi Seiyaku Co Ltd ムラミルペプチド誘導体
FR2564096B1 (fr) * 1984-05-11 1988-02-19 Anvar Derives lipophiles de muramylpeptides ayant des proprietes d'activation des macrophages, compositions les contenant et procede pour les obtenir

Also Published As

Publication number Publication date
FI903232A7 (fi) 1990-12-30
HU903880D0 (en) 1990-11-28
US5210072A (en) 1993-05-11
AU636150B2 (en) 1993-04-22
CA2019922A1 (en) 1990-12-29
HUT54180A (en) 1991-01-28
PL163888B1 (pl) 1994-05-31
IE902345A1 (en) 1991-01-16
JPH03135998A (ja) 1991-06-10
DE69023559T2 (de) 1996-06-27
EP0406175A2 (en) 1991-01-02
IL94885A0 (en) 1991-04-15
NZ234270A (en) 1993-02-25
PT94517A (pt) 1991-02-08
EP0406175B1 (en) 1995-11-15
MY105727A (en) 1994-11-30
AU5787590A (en) 1991-01-03
HU205147B (en) 1992-03-30
JPH0737479B2 (ja) 1995-04-26
ATE130313T1 (de) 1995-12-15
EP0406175A3 (en) 1992-04-01
DE69023559D1 (de) 1995-12-21
IE902345L (en) 1990-12-29
KR910000775A (ko) 1991-01-30
FI903232A0 (fi) 1990-06-27
IL94885A (en) 1994-07-31
PL285842A1 (en) 1991-03-11

Similar Documents

Publication Publication Date Title
ES2118992T3 (es) Derivados ciclicos, medicamentos que contienen estos compuestos y procedimiento para su preparacion.
ES2070253T3 (es) Ciclohexanoles sustituidos utiles como agentes para el sistema nervioso central.
ES2184797T3 (es) Uso de antagonistas de serotonina (5ht3) para el tratamiento de la fibromialgia.
ES2195970T3 (es) L-ribavirina y usos de la misma.
ES2093979T3 (es) Esteres nitricos de derivados del acido 2-(2,6-dihalofenilamino)fenilacetico y su procedimiento de preparacion.
CO4700455A1 (es) Derivados tetraciclicos y proceso para su preparacion
ES2074429T3 (es) Derivados de fluorocitidina, su preparacion y preparados medios que los contienen.
LU88712I2 (fr) TAXOTERE-Décotaxel
ES2154674T3 (es) Derivados de 1,5-benzodiacepinas con actividad antagonista o agonista de cck.
ES2107518T3 (es) Polimeros estabilizados con heteroatomos en la cadena principal.
ECSP055746A (es) Antagonistas de cgrp elegidos, procedimiento para su preparación, así como su empleo como medicamentos
MX168494B (es) Nuevos derivados de pirazolina su preparacion y su uso como plaguisidas
ES2149883T3 (es) Sintesis quimica de taxol y de derivados de taxol.
ECSP055747A (es) Antagonistas de cgrp elegidos, procedimiento para su preparación, así como su empleo como medicamentos
ECSP034924A (es) Derivados sustituidos del 1-oxa-2,8-daza-espiro[4,5]dec-2-eno
ES2077010T3 (es) Eteres de celulosa no ionicos solubles en agua y su uso en pinturas.
ES2011296B3 (es) Derivados de benzo[b]tiofeno y benzo [b]furano carboxamidas, sus procedimientos de preparacion y los medicamentos que los contienen.
DE69004112D1 (de) Anordnung zur Hochspannungsversorgung einer Röntgenröhre.
GT199900011A (es) Nuevos derivados del acido dihidroxihexanoico
ES2099362T3 (es) Derivados de octahidrofenantreno.
PT97884A (pt) Processo para a preparacao de derivados de radicicol e de composicoes farmaceuticas que os contem
NO924670L (no) Derivater av 6-aminooktahydroindolizintriol
ES2057341T3 (es) Ciclohexenos substituidos como agentes para el sistema nervioso central.
DE59102395D1 (de) Fluorbenzolsulfonamide.
UY26492A1 (es) Bencimidazoles, su preparación y su empleo como medicamentos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 406175

Country of ref document: ES